John Muschamp - Publications

Affiliations: 
Pharmacology Temple University School of Medicine, Philadelphia, PA, United States 
Area:
Glutamate
Website:
http://www.temple.edu/medicine/faculty/m/muschamp.asp?pms=muschamp%20jw%5Bau%5D

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Benham RS, Choi C, Hodgson NW, Hewage NB, Kastli R, Donahue RJ, Muschamp JW, Engin E, Carlezon WA, Hensch TK, Rudolph U. α2-containing γ-aminobutyric acid type A receptors promote stress resiliency in male mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 34408277 DOI: 10.1038/s41386-021-01144-w  0.531
2018 Simmons SJ, Leyrer-Jackson JM, Oliver CF, Hicks C, Muschamp J, Rawls SM, Olive MF. Dark Classics in Chemical Neuroscience: "Cathinone-derived Psychostimulants". Acs Chemical Neuroscience. PMID 29714473 DOI: 10.1021/Acschemneuro.8B00147  0.604
2017 Philogene-Khalid HL, Simmons SJ, Nayak S, Martorana RM, Su SH, Caro Y, Ranieri B, DiFurio K, Mo L, Gentile TA, Murad A, Reitz AB, Muschamp JW, Rawls SM. Stereoselective differences between the reinforcing and motivational effects of cathinone-derived 4-methylmethcathinone (mephedrone) in self-administering rats. Acs Chemical Neuroscience. PMID 28885007 DOI: 10.1021/Acschemneuro.7B00212  0.58
2017 Simmons SJ, Martorana R, Philogene-Khalid H, Tran FH, Gentile TA, Xu X, Su S, Rawls SM, Muschamp JW. Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats. Psychopharmacology. PMID 28786030 DOI: 10.1007/S00213-017-4709-3  0.67
2017 Gentile TA, Simmons SJ, Watson MN, Connelly KL, Brailoiu E, Zhang Y, Muschamp JW. Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28741623 DOI: 10.1038/Npp.2017.158  0.665
2017 Philogene-Khalid HL, Simmons SJ, Muschamp JW, Rawls SM. Effects of ceftriaxone on conditioned nicotine reward in rats. Behavioural Pharmacology. PMID 28704277 DOI: 10.1097/Fbp.0000000000000314  0.563
2017 Gentile TA, Simmons SJ, Barker DJ, Shaw JK, España RA, Muschamp JW. Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addiction Biology. PMID 28419646 DOI: 10.1111/Adb.12507  0.634
2016 Simmons SJ, Gregg RA, Tran FH, Mo L, von Weltin E, Barker DJ, Gentile TA, Watterson LR, Rawls SM, Muschamp JW. Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats. Addiction Biology. PMID 27910188 DOI: 10.1111/Adb.12479  0.608
2016 Simmons SJ, Gentile TA, Mo L, Tran FH, Ma S, Muschamp JW. Nicotinic Receptor Blockade Decreases Fos Immunoreactivity within Orexin/Hypocretin-Expressing Neurons of Nicotine-Exposed Rats. Behavioural Brain Research. PMID 27491589 DOI: 10.1016/J.Bbr.2016.07.053  0.616
2015 Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW, Borgland SL. Orexin/hypocretin role in reward: implications for opioid and other addictions. British Journal of Pharmacology. 172: 334-48. PMID 24641197 DOI: 10.1111/Bph.12639  0.346
2014 Muschamp JW, Hollander JA, Thompson JL, Voren G, Hassinger LC, Onvani S, Kamenecka TM, Borgland SL, Kenny PJ, Carlezon WA. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proceedings of the National Academy of Sciences of the United States of America. 111: E1648-55. PMID 24706819 DOI: 10.1073/Pnas.1315542111  0.607
2014 Donahue RJ, Muschamp JW, Russo SJ, Nestler EJ, Carlezon WA. Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice. Biological Psychiatry. 76: 550-8. PMID 24495460 DOI: 10.1016/J.Biopsych.2013.12.014  0.617
2014 Russell SE, Rachlin AB, Smith KL, Muschamp J, Berry L, Zhao Z, Chartoff EH. Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats. Biological Psychiatry. 76: 213-22. PMID 24090794 DOI: 10.1016/j.biopsych.2013.07.042  0.676
2013 Muschamp JW, Carlezon WA. Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation. Cold Spring Harbor Perspectives in Medicine. 3: a012005. PMID 23293139 DOI: 10.1101/cshperspect.a012005  0.59
2012 Reynolds LM, Engin E, Tantillo G, Lau HM, Muschamp JW, Carlezon WA, Rudolph U. Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2531-40. PMID 22763624 DOI: 10.1038/Npp.2012.115  0.553
2012 Muschamp JW, Nemeth CL, Robison AJ, Nestler EJ, Carlezon WA. ΔFosB enhances the rewarding effects of cocaine while reducing the pro-depressive effects of the kappa-opioid receptor agonist U50488. Biological Psychiatry. 71: 44-50. PMID 21962331 DOI: 10.1016/j.biopsych.2011.08.011  0.664
2011 Muschamp JW, Van't Veer A, Carlezon WA. Tracking down the molecular substrates of stress: new roles for p38α MAPK and kappa-opioid receptors. Neuron. 71: 383-5. PMID 21835335 DOI: 10.1016/j.neuron.2011.07.018  0.738
2011 Knoll AT, Muschamp JW, Sillivan SE, Ferguson D, Dietz DM, Meloni EG, Carroll FI, Nestler EJ, Konradi C, Carlezon WA. Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biological Psychiatry. 70: 425-33. PMID 21531393 DOI: 10.1016/J.Biopsych.2011.03.017  0.656
2011 Muschamp JW, Van't Veer A, Parsegian A, Gallo MS, Chen M, Neve RL, Meloni EG, Carlezon WA. Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 3095-103. PMID 21414930 DOI: 10.1523/Jneurosci.5973-10.2011  0.753
2007 Muschamp JW, Hull EM. Melanin concentrating hormone and estrogen receptor-alpha are coexstensive but not coexpressed in cells of male rat hypothalamus. Neuroscience Letters. 427: 123-6. PMID 17933463 DOI: 10.1016/j.neulet.2007.09.031  0.594
2007 Muschamp JW, Dominguez JM, Sato SM, Shen RY, Hull EM. A role for hypocretin (orexin) in male sexual behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 2837-45. PMID 17360905 DOI: 10.1523/JNEUROSCI.4121-06.2007  0.755
2007 Hull EM, Dominguez JM, Muschamp JW. Neurochemistry of male sexual behavior Handbook of Neurochemistry and Molecular Neurobiology: Behavioral Neurochemistry, Neuroendocrinology and Molecular Neurobiology. 37-94. DOI: 10.1007/978-0-387-30405-2_2  0.639
2004 Lagoda G, Muschamp JW, Vigdorchik A, Hull EM. A nitric oxide synthesis inhibitor in the medial preoptic area inhibits copulation and stimulus sensitization in male rats. Behavioral Neuroscience. 118: 1317-23. PMID 15598140 DOI: 10.1037/0735-7044.118.6.1317  0.591
2004 Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiology & Behavior. 83: 291-307. PMID 15488546 DOI: 10.1016/j.physbeh.2004.08.018  0.74
2004 Muschamp JW, Regina MJ, Hull EM, Winter JC, Rabin RA. Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Research. 1023: 134-40. PMID 15364028 DOI: 10.1016/J.Brainres.2004.07.044  0.551
2004 Dominguez JM, Muschamp JW, Schmich JM, Hull EM. Nitric oxide mediates glutamate-evoked dopamine release in the medial preoptic area. Neuroscience. 125: 203-10. PMID 15051159 DOI: 10.1016/j.neuroscience.2004.01.022  0.672
2002 Muschamp JW, Siviy SM. Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats. Pharmacology, Biochemistry, and Behavior. 73: 835-42. PMID 12213529 DOI: 10.1016/S0091-3057(02)00910-3  0.308
Show low-probability matches.